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Abstract:  The objectives  of this study were to document the psychosocial characteristics of treatment-adherent, 
successfully treated HIV patients and to examine the relationships between psychosocial variables. The sample was 
composed of 133 persons living with HIV, with optimal adherence to antiretroviral therapy and with no detectable viral 
load. The psychosocial profile of the cohort showed that participants had moderate levels of stress, used a wide range of 
strategies to adjust to their situation and perceived their social support to be good. As well, they evaluated their quality of 
life (Medical Outcome Study-HIV) as moderate. Quality of life in psychological domain is largely explained by perceived 
stress (53%). Quality of life in physical domain is largely dependent on discomfort reported arising from HIV-associated 
symptoms and treatment (39%). Findings suggest that treatment-adherent, successfully treated patients with HIV are still a 
fragile population, and that it is essential to provide interventions that reinforce their ways of coping. 
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INTRODUCTION 
  In spite of the advent of new treatments, infection with 
the human immunodeficiency virus (HIV) is still a major 
public health preoccupation. The epidemic began about 20 
years ago and, since then, more than 33 million people have 
been infected by the virus in 2007 [1]. The epidemic 
continues to spread extremely rapidly in Central Asia, South 
Africa, Latin America and the Caribbean countries. In 
western countries new combinations of antiretroviral drugs 
have transformed the daily life of HIV persons. Although, 
they are no longer confronted with a rapid and fatal 
prognosis, they still have to cope with living with a chronic 
disease [2]. 
  The administration of antiretroviral therapy (ART) has 
increased since its introduction in 1996. At present, 94% of 
HIV patients living in western countries are estimated to 
have access to such treatment [3]. The beneficial effect of 
these new treatments on viral load and CD4 levels has made 
a considerable contribution to improving patients’ state of 
health and reducing morbidity, mortality and hospitalization 
[4]. Nevertheless, living with HIV is still a constant 
challenge. As well as facing the problems related to chronic 
disease, the person living with HIV has to adjust to a 
complex and changing treatment regimen and adhere to it.  
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For several years now, there has been a considerable 
improvement in ART and regimens with fewer pills to take, 
taking those less often are now available and they involve 
fewer meal restrictions [5]. However, the impact of this 
therapy on his or her quality of life can be significant and it 
is a variable of paramount importance amongst this 
population [6] and one which deserves closer investigation. 
  Quality of life is a multi-dimensional construct [7, 8] that 
refers to physical, psychological and social aspects of an 
individual. These are indicators of how well an individual 
functions in daily life as well as of how the individual’s 
perceptions of how health status influences his or her life. 
Johnson, Catz, Remien et al. [8] stress that the concept of 
quality of life is an important result variable that is used in 
clinical trials, cost-effectiveness studies and research 
exploring quality of care. In fact, quality of life has emerged 
as a significant outcome measure in the context of chronic 
disease, in particular among persons living with HIV [9]. 
Earlier studies, conducted prior to the introduction of 
antiretroviral therapy, showed a pattern of deterioration in 
quality of life over time; this was particularly evident for 
those with physical impairment [10, 11]. Since the advent of 
antiretroviral therapy, the general trend shows little change 
or a modest improvement in quality of life. Burgoyne and 
colleagues [12] evaluated changes in quality of life over a 
four-year period among 41 adult outpatients living with HIV, 
most of whom were consistently on antiretroviral therapy. 
They reported that quality of life was generally stable or 
slightly improved over time, for the overall sample. In a 
more recent study, Mannheimer, Matts, Telzak et al. [9] 
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to four months of treatment with the antiretroviral therapy, 
and that this persisted at 12 months. 
  It is an advantage for both clinicians and researchers to 
have a better understanding of factors that may improve 
quality of life for HIV persons [6]. As mentioned by Stangl 
and colleagues [13] a precursor to improving QoL is 
knowledge of the factors that influence it, upon which 
appropriate interventions could be developed. The 
psychosocial variables most frequently related to their 
quality of life are social support [14-18] coping strategies 
[17, 19, 20]
 and psychological status [18, 21, 22]. Before the 
introduction of antiretroviral therapy, CD4 cell counts [23] 
and HIV disease stage [24] were the factors most frequently 
related to quality of life. Burgoyne’s [12] results indicate that 
quality of life is currently less sensitive to immunologic and 
virologic changes than to symptom changes. Mannheimer 
and colleagues [9] have also recently emphasized the 
possible contributing role of treatment adherence in 
explaining the quality of life of persons living with HIV. 
Although researchers are increasingly interested in gaining a 
better understanding of contributing quality of life factors in 
HIV persons [25], ambiguities continue to persist. 
  Few studies seem to have documented the experience of 
persons who apparently succeed with daily therapy. As such, 
it is timely to investigate factors determining quality of life 
in a population of patients who adhere to treatment and 
whose treatment is effective. Using a salutogenic approach 
confers both originality and value added to this avenue of 
study. Briefly, the knowledge that people viewed as ‘non-
problem’ have recourse to in dealing with and resolving 
problematic situations they encounter can be a starting point 
for setting up new techniques for taking charge and for 
prevention. 
THEORETICAL MODEL OF STRESS COPING 
  In order to guide the selection of the explanatory 
variables for quality of life, we selected a theoretical model 
of stress/coping, developed by Lazarus and Folkman [26]. 
Integrated in a transactional approach to stress, it gives a 
major emphasis to cognitive evaluation of the stressful 
situation, relying on both primary and secondary appraisals. 
Primary appraisal refers to the individual’s initial perception 
of an event: it may be considered as trivial (without 
significance), a loss (bodily, material, relational), a threat 
(prospect of loss) or a challenge (prospect of benefit). When 
the event is perceived as a loss or a threat and is therefore 
stressful, the individual experiences negative emotions such 
as shame or anger. The individual then shifts into secondary 
appraisal, weighing up what can be done to cope with the 
threat or avoid harm, and speculating on the potential for 
gain. Following primary and secondary appraisal, the 
individual chooses the appropriate coping options. Such a 
theoretical framework of primary and secondary appraisal is 
strongly recommended in looking at the problems that 
people living with a chronic illness experience [6]. It allows 
us to gain a full appreciation of the different ways 
individuals adapt to a situation they perceive to be stressful. 
  Living with HIV means that every day it is necessary to 
come to terms with a stigmatizing disease with distinct 
constraints. According the Lazarus and Folkman theory [26], 
the individual’s personal appraisal of this situation will have 
repercussions on the way he or she adjusts to the condition 
and eventually on his or her ultimate quality of life. We used 
their theoretical model [26] to identify the different variables 
in our study as follows: the stress of living with HIV, 
physical symptoms experienced, coping strategies used, 
coping resources available in the form of perceived support, 
and quality of life (Fig. 1). 
RESEARCH OBJECTIVE 
  The objectives of this study were to document the 
psychosocial characteristics of treatment-adherent, 
successfully treated HIV patients and to examine the 
relationships between stress experienced, discomfort 
reported arising from HIV-associated symptoms and 
treatment, perceived social support, coping strategies used, 
and quality of life. We performed our study with a cohort of 
successfully treated patients in France living with HIV. 
METHODS 
Design and Study Population 
  Our “Promosud” study was conducted in six HIV units in 
the south-west of France, where we followed a cohort of 
HIV-infected persons of the course of a year. Participants 
were included over a six-month period (second semester of 
2004) and were all adherents at inclusion. As recommended 
in French national guidelines [27] the measure of adherence 
combined objective and subjective evaluations and was 
determined from a self-reported questionnaire and the 
measurement of viral load. A person was considered as 
adherent if he or she met two criteria: a viral load of 50 
copies or less, which is the standard threshold used in the 
various centres, and a 95% adherence rate reported on the 
questionnaire in the last seven days [28]. We selected a 
convenience sample of 147 persons and ultimately obtained 
complete data for 133 individuals. Sample size was 
compatible with the requirements of statistical analysis (two-
tailed alpha risk 5%, study power 80%, SD 20). We used two 
exclusion criteria: either uncontrolled psychiatric problems 
or a neurological disorder affecting the person’s ability to 
participate (e.g., cerebral toxoplasmosis). 
Measurement 
  Various measurement tools were used in this study – 
some for respondent selection and others for measuring the 
variables selected. 
Instruments for Selecting Respondents 
  We evaluated treatment adherence by two means: 
measurement of viral load and administration of a 
questionnaire [29]. Participants responded to seven questions 
in the questionnaire, making it possible to determine how 
many times each had forgotten to take his or her medication. 
The questionnaire was constructed in such a way that the 
respondent was placed in a context where events and 
situations could have led to forgetfulness. Individuals were 
considered as being adherent if the number of times they 
forgot the medication was 5% or less than the number of 
pills to be taken over seven days (i.e., 95% adherence). The 
“95% rule” for adherence has been established by Paterson, 
Swindells, Mohr et al. [28] the as the fundamental standard. 
The questionnaire has been validated against changes in viral 
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72%, odds ratio 6.15) [29]. Viral load is an indirect 
measurement of adherence in as much as, when a person is 
adherent, his or her viral load is undetectable or less than 50 
copies/ml of plasma (viral load: plasma HIV RNA is 
measured using the b DNA method and the limit of detection 
of the test is 50 copies/ml of plasma) [30, 31]. 
Instruments for Measuring the Variables 
  Side-effects of HIV and treatment were measured with 
the 20-item HIV Symptom Index, developed by Justice, 
Holmes, Gifford et al. [32]. The scale examines both the 
frequency and the number of physical symptoms, as well as 
the degree of discomfort caused. This instrument is easy to 
use and has demonstrated appreciable psychometric 
properties, including good construct validity. The Cronbach 
Alpha coefficient was also 0.83 for this study. 
  Social support was measured with the Social Provision 
Scale [33], which is composed of 24 items, measuring six 
dimensions of social support (attachment, reliable alliance, 
guidance, social integration, reassurance of worth and 
nurturance) on five-point scales. It has been validated in a 
sample of 1792 persons and has been used with HIV 
clientele [34]. This tool has demonstrated appreciable 
discriminant and concurrent validities, as well as internal 
consistency (varying to .85 and .92 according to different 
studies). For this study, internal consistency of the scale was 
0.84. 
  Stress in people living with HIV was measured with the 
Stress Appraisal Measure scale (SAM) developed by 
Peacock and Wong [35]. This instrument assesses three 
dimensions of primary appraisal: threat, challenge and 
centrality. Secondary appraisal is also measured for three 
dimensions: control by self, control by others and 
uncontrollability (lack of control). In addition, in order to 
examine the relationship between these dimensions of stress 
appraisal and the overall stress process, Peacock and Wong 
elaborated a ‘stressfulness’ subscale which reflects an overall 
appraisal of stress. This scale consists of 28 items and seven 
subscales. Responses are chosen on a five-point Likert scale 
(1: not at all – 5: too much). Its psychometric properties are 
satisfactory, including good construct validity and internal 
consistency with Alpha ranging from 0.74 and 0.90 for these 
subscales. The Cronbach Alpha coefficient observed on 
administration of the questionnaire ranged from 0.83 to 0.84 
for the various dimensions. 
  Coping strategies were measured with an abridged version 
of the Ways of Coping Questionnaire developed by Lazarus 
and Folkman [26]. This three-dimensional scale of 21 items 
comprises three sub-dimensions: social support seeking, 
positive reappraisal/problem solving, and distancing/avoidance. 
The psychometric properties are satisfactory, including internal 
consistency (0.76 for distancing/avoidance, 0.85 for social 
support seeking and 0.80 for positive reappraisal/problem 
solving). The Cronbach Alpha coefficient for all three 
dimensions of this study ranged from 0.83 to 0.84. 
  Quality of life was measured using the Medical Outcome 
Study-HIV scale from Wu and colleagues [36]. This scale is 
composed of 35 questions that assess 11 aspects of health in 
persons living with HIV: general health perceptions, pain, 
physical functioning, role functioning, social functioning, 
mental health, energy, health distress, cognitive functioning, 
quality of life and health transition. The scale thus yields an 
overall score for physical health and for mental health. More 
specifically, physical health status (PHS) consists of physical 
functioning, pain, role functioning, social functioning and 
general health. Similarly, mental health status (MHS) 
includes the energy, cognitive functioning, quality of life, 
health distress and mental health dimensions. The 
psychometric properties of both the overall scale and its 
subscales are satisfactory. Wu, Revicki, Jacobson and Malitz 
[37] reported Cronbach Alpha coefficients over 0.78 for all 
subscales. For our study, Cronbach Alpha coefficients 
ranged from 0.83 to 0.85. 
 We obtained the following sociodemographic 
information with a questionnaire: gender, age, level of 
education and employment status. This questionnaire also 
included questions related to HIV infection, such as length of 
time they had been aware they were seropositive, drug 
treatment and duration of treatment. 
Data Collection 
  The process of data collection was largely based on 
Dillman’s [38] recommendations for facilitating staff 
involvement, thus maximizing the participation rate. At the 
time of their medical visit or of a day hospitalization, the 
physician gives the patients an information sheet about the 
study and a document relating the ethical requirements in 
 
Fig. (1). Relationships between the selected variables under the stress/coping model. 
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force (anonymity of the respondent as well as voluntary 
participation). The participants were entirely free to 
participate and those who did want to were asked to sign 
‘informed consent’ forms. Approval for the study was 
obtained from the Commission Nationale de l’Informatique 
et Liberté (CNIL). After complying with the usual ethical 
requirements (anonymity, voluntary participation), a self-
report survey was given to participants: this consisted of five 
measurement scales and a sociodemographic questionnaire. 
In all, they had to complete three self-report questionnaires: 
at baseline, six (M6) and 12 months (M12). If necessary, 
participants were able to ask a pre-identified associate in 
each center for clarifications on the questionnaire. Five 
percent of respondents required this support. Respondents 
took between 30 and 45 minutes to fill out the questionnaire. 
Ultimately, 89% of the questionnaires were fully completed 
and available for analysis. 
Data Analysis 
  First, we used descriptive statistics such as frequency 
distributions and measurements of central tendency and 
dispersion to describe the characteristics of the selected 
sample and the variables of interest. We then performed 
correlation analysis to explore the existence of the 
relationships between the variables of interest, as proposed in 
the Lazarus and Folkman [26] theoretical model (Fig. 1). 
Finally, multivariate stepwise linear regression determined 
the variables predicting quality of life in persons living with 
HIV. All analyses were carried out using SAS software. A 
critical level of less than .005 was considered as statistically 
significant. 
RESULTS 
Descriptive Characteristics 
  The sample was composed predominantly of men, with a 
mean age of 43 years. Participants had been aware of their 
seropositivity for a mean of 11.45 years and had been 
receiving treatment for a mean of 8.67 years. Descriptive 
statistics for variables of interest are presented in Tables 1 & 
2. Participants had moderate scores on Global Stress (2.18 on 
a scale of 1 to 5-too much). Participants reported high scores 
on the Social Support scale: the overall score was 91.28 (on 
a scale of 24 to 120). For Side-effects, the overall score 
observed was 1.61, on a scale of 0–3. Two-thirds of the 
sample stated they had moderate discomfort as a result of at 
least one side-effect. The strategies most often used were 
Positive Reappraisal/Problem Solving, followed by Escape 
or Avoidance, with Support Seeking being last. However, the 
difference between the means of the various strategies was 
minimal. Consequently, participants made alternate use of 
these three strategies to face the stressful situations arising 
from living with HIV. Finally, results related to quality of 
life yielded very similar Physical Health and Mental Health 
scores, lying within the mean. 
Relationships Between the Variables 
  As proposed in the Lazarus and Folkman [26] theoretical 
model, we first studied the relationships between Side Effects, 
Social Support and Stress/Coping (Table 3), followed by those 
between Stress and Coping (Table 4). Relationships between 
the different variables we retained and the two dimensions of 
quality of life are displayed in Table 5. 
Table1.  Main Features of the Study Population (N=133) 
 
Variables M  SD  N  (%) 
Socio-Demographics      
Gender      
Men     97  (72.8%) 
Women     36  (27.2%) 
Level of education       
Elementary     19  (15.08%) 
High School      68 (53.97%) 
University     39  (30.95%) 
Working Situation       
Employed     74  (58.73%) 
Unemployed     40  (31.75%) 
Retired     12  (9.52%) 
Age 43  11   
Time since HIV  11.45  9.1   
Duration of treatment  8.67  3   
Living alone       
No     72  (57.1%) 
Yes     54  (42.9%) 
 
  There was a positive relationship between Side effects 
and the global Stress scores (r = 0.47, p < 0.001). As well, 
we observed a positive relationship between the global 
scores for Side Effects and Escape/Avoidance strategies (r = 
0.39, p < 0.001). The global score for Social Support was 
associated negatively with Stress (r = - 0.43, p < 0.001) and 
positively with strategies for Reappraisal/Problem Solving (r 
= 0.25, p  < 0.005) (Table 3). Also, analysis revealed that 
notions of Challenge (r = 0.40, p < 0.001) and Control by 
Self (r = 0.32, p < 0.001) were positively related to Positive 
Reappraisal/Problem Solving strategies (Table 4). 
  Finally, analysis of the relationships between the various 
variables we retained and the two quality of life dimensions 
(PHS, MHS) (Table 5) showed that there was a positive 
relationship between the Physical Health score and Social 
support (r = 0.35. p < 0.001) and a negative relationship with 
both Stress (r = -0.50, p < 0.001), Side Effects (r = -0.67, p < 
0.001) and Escape/Avoidance strategies(r = -0.26, p  < 
0.003). We observed negative relationships between Mental 
Health and Escape/Avoidance strategies (r = -0.34, p  < 
0.001), Stress (r = -0.70, p < 0.001) and Side Effects (r = -
0.68, p < 0.001); however, there was a positive relationship 
with Social Support (r = 0.58, p < 0.001). 
Explanatory Factors of Quality of Life 
  Following the results obtained for the different variables 
studied, we performed stepwise multiple regression analysis 
to examine their relation to the outcome variable. We took 
two dimensions of Quality of Life - Mental Health Status 
and Physical Health Status - as dependent variables. All   
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Table 2  Main Features of the Study Population (n=133) 
 
Variables Mean  SD 
Stress appraisal (1)    
Threat 2.33  0.93 
Challenge 3.59  0.78 
Centrality 3.07  1.09 
Control by self  3.68  0.77 
Control by others  3.42  0.74 
Uncontrollability 1.88  0.79 
Stress (overall appraisal)  2.18  0.70 
Social support (2)    
Overall score  91.28  8.8 
Attachment 15.4  3.68 
Reliable alliance  16.83  2.88 
Guidance 13.72  2.2 
Social integration  14.68  3.2 
Reassurance of worth  15.0  3.03 
Nurturance 15.55  2.94 
Side effects (3)    
Fatigue 2.13  0.63 
Anxiety 1.88  0.69 
Sexual problems  1.87  0.78 
Difficulty in sleeping  1.80  0.71 
Fever 1.42  0.65 
Dizziness 1.40  0.64 
Respiratory problems  1.39  0.63 
Loss of appetite  1.34  0.59 
Overall score  1.61  0.38 
Coping strategies (4)    
Support seeking   2.05  0.7 
Positive reappraisal/Problem-solving  2.51  0.69 
Escape/Avoidance 2.12  0.71 
Quality of life (5)    
General physical health score  51.57  9 
General mental health score  50.13  9.54 
Perceived general health  52.54  20.4 
Pain 76.2  24.00 
Physical functioning  81.22  22.55 
Role functioning  79.37  35.93 
Social functioning  82.54  22.91 
Mental health  66.64  19.39 
Energy 63.73  19.69 
Health distress  81.35  22.06 
Cognitive functioning  76.51  22.33 
Quality of life  70.64  19.26 
Health transition  53.18  12.24 
Possible score range from (1) 1-5; (2) 4-20; (3) 1-3; (4) 1-4; (5) 0-100. 
 
variables associated with quality of life at the threshold of 
0.2 in bivariate analysis were entered in the logistic 
regression model. The explanatory variables included in the 
statistical model were Side Effects, Social Support, 
Perceived Stress and Coping strategies. These psychosocial 
variables explained 69 % of Mental health status variance: 
Perceived Stress (53%), Side Effects (9 %), Social Support 
(5%) and Positive Reappraisal/Problem Solving Strategies 
(2%) (Table 6). Physical Health Status, one dimension of 
Quality of Life, has been explained by Side Effect (39%), 
Stress (4%) and Positive Reappraisal/Problem Solving 
Strategies (2%) (Table 7). 
DISCUSSION 
  The criteria for the selection of this cohort combined two 
adherence indicators: a viral load of 50 copies or less and an 
adherence level of 95% or more, as self-reported on the 
questionnaire. Our interest in this cohort of persons who 
were treatment-adherent at inclusion and whose treatment 
was successful, was to draw up a descriptive psychosocial 
portrait of their characteristics and to explore explanatory 
factors for Quality of Life. 
  On average, the participants in our study had been 
seropositive for 12 years and had been receiving treatment 
for nine years. This latter figure coincides with the advent of 
tri-therapy. The psychosocial profile of the cohort showed 
that participants had moderate levels of stress, used a varied 
repertoire of coping strategies to adjust to their situations and 
enjoyed good peer support. They assessed their quality of 
life as moderate in both physical and psychological 
domains.  Scores for Stress and Quality of Life that we 
obtained were similar to those reported by Ruano [39] in a 
population living with HIV in Spain. However, our global 
score for Social Support (91.3) is greater than that reported 
by Godin Côté, Naccache, Lambert and Trottier [34] in their 
cohort of 400 people receiving antiretroviral therapy in 
Quebec. 
  Quality of life in the psychological domain is largely 
dependent on perceived stress, which explains a large part of 
the variance. Perceived stress refers to overall stress, of 
which, as theoretically conceptualized by Lazarus and 
Folkman [26] there are two elements: primary appraisal and 
secondary appraisal. In relation to stress appraisal, a closer 
analysis showed that respondents who perceived difficult 
situations as a challenge (primary appraisal) and had a 
perception of control (secondary appraisal) were more likely 
to use positive reappraisal and problem-solving strategies. 
The aspect of control is an important component in the 
process by which the individual copes with and adjusts to the 
stressors of daily life. If the individual living with HIV 
perceives the situation as a challenge, and one which can be 
controlled, he or she tends to use active coping strategies to 
deal with stress situations that could affect quality of life. 
Weaver and colleagues [20] found that cognitive coping 
strategies are related to quality of life and their influence 
appears to be mediated through perceptions of life 
stressfulness. Taking into account the preponderance of 
stress in explaining the psychological component of quality 
of life, it is essential that the interventions delivered should 
provide the person living with HIV with the means of 
managing difficult situations. Quality of Life of Adherent HIV Patients  The Open Nursing Journal, 2009, Volume 3    15 
 
 
Table 4  Correlations Between Stress and Coping Skills 
 
Variables   Support  
Seeking 
Positive Reappraisal/ 
Problem Solving  
Escape- 
Avoidance  
Stress Appraisal 
Threat NS  NS    NS 
Challenge  NS   0.40 *  NS 
Centrality NS  NS  NS 
Control by self   NS  0.32*  NS  
Control by others  NS  NS  NS 
Uncontrollability NS  NS  NS 
Stress (overall appraisal)  NS NS  NS 
*p<0.001. 
 
Table  5  Correlations Between Coping, Stress, Side effects, 
Social Support and Quality of Life 
 
Variables   Quality of  
Life (PHS) 
Quality of  
Life (MHS) 
Support seeking  NS  NS 
Positive reappraisal/Problem solving  NS  NS 
Escape – avoidance  -0.26 *  -0.34 ** 
Stress (overall appraisal)  -0.50** -0.70** 
Side effects (overall score)  -0.67**  -0.68** 
Social support (overall score)  0.35**  0.58** 
* p<0.003, **p<0.001. 
 
  Quality of life in the physical domain is largely a 
function of side effects: this explains a large part of the 
variance. This finding is corroborated by others [40, 41] who 
have reported that quality of life was worse and deteriorated 
more rapidly among persons who have more physical 
symptoms. According to Burgoyne and Tan [42] the 
deteriorations in quality of life that are due to illness 
symptoms in the pre-ART treatment era may have been 
replaced by important deterioration arising from side effects 
in the ART era. In relation to side effect, a closer analysis 
showed that when respondents experienced a side-effect, 
they experienced more stress and tended to deny or to escape 
from it, rather than face up to it. It is plausible that the 
presence of symptoms is perceived as stressful and difficult 
to modify, and that, when confronted by this situation, 
cognitive distancing strategies are used. As we know, side 
effects can be better managed; therefore, support 
interventions should be provided with this aim in mind. 
Participants were bothered by fatigue, which was the most 
frequent symptom and caused them the most problems. 
Johnson and colleagues [43] and Vogl and collegues [44] 
also observed that fatigue was the symptom most often 
reported, affecting about 85% of their sample. Fatigue is 
linked with multiple factors: an advanced stage of the 
disease, opportunistic infections, poor nutritional status, and 
treatment with antiretroviral drugs, hormone deficiency and 
anaemia. It is one of the most common clinical symptoms 
affecting quality of life in HIV-positive persons [45] and 
should not be overlooked or minimized as a symptom of 
chronic HIV infection. It should be systematically evaluated 
and addressed, even in successfully treated, adherent 
persons. 
  Our intention in this study was also to examine the 
relationships between the Stress-Coping tandem and other 
variables, notably Social Support. Our findings show that 
those who perceive themselves as having a high level of 
support are more likely to experience less stress and use 
positive reappraisal and problem-solving strategies. The 
presence of a comforting, effective social network appears to 
enable the individual to confront and analyze difficult 
situations in a positive way. The literature documents the 
buffering effect of social support in the adjustment process 
[46] and in health behaviours – in this instance, treatment 
adherence [47, 48]. In the adjustment process, support is 
seen as a coping resource that gives the individual access to a 
varied repertoire of strategies. Burgoyne and Renwick [14] 
examined the interplay between social support and quality of 
life in a cohort of persons living with HIV. They found that 
self-perceived quality of life is indeed mediated by social 
Table 3  Correlations Between Side Effects, Social Support and Stress/Coping Skills 
 
Variables   Stress (Overall Appraisal   Support Seeking   Positive Reappraisal/Problem Solving   Escape-Avoidance  
Side effects (overall score)   0.47**  NS  NS  0.39** 
Social support (overall score)   -0.43** NS  0.25*  NS 
* p< 0.005, **p<0.001. 
Table 6  Multiple Regression Analysis: Predictors of Quality of Life (MHS) 
 
Explanatory Variables  BETA  B Standardise  R2  Cumulative R-Square  p 
Stress (overall appraisal)  -5.4  -0.46  0.53  0.53  p<0.0001 
Side effects  - 0.4  -0.31  0.09  0.62  p<0.0001 
Social support  4.1  0.23  0.05  0.67  p<0.0001 
Positive reappraisal/Problem solving  1.75  0.12  0.02  0.69  0.02 16    The Open Nursing Journal, 2009, Volume 3  Coté et al. 
support. Also, Liu, Johnson, Ostrow, Silvestre, Visscher and 
Jacobson [18] and Jia [17] have shown that social support is 
a very important factor for patients’ mental health quality of 
life. Social support, as a coping resource, should therefore be 
taken into account in the delivery and follow-up of 
interventions to increase quality of life for these clients. 
  This study has documented relationship between quality 
of life and stress experienced, discomfort reported from 
HIV-associated symptoms and treatment, perceived social 
support, coping strategies used among a cohort of 
successfully treated patients in France living with HIV. 
However, our study has some limitations. Because of its 
cross sectional design, it provides a portrait of the situation at 
a given point in time and makes no allowance for any 
direction or causality in the relationships examined. The 
findings therefore appear more exploratory than 
confirmatory. Also, our findings are thus limited to the 
population studied, which, at the time of participation, were 
characterized by optimal adherence and successful treatment. 
We have gained an understanding of the contributing role of 
perceived stress and perceived side effect in the mental and 
physical domains of quality of life and that these are two 
important factors to target in our interventions for improving 
quality of life. As well, in the relationship between perceived 
social support and the stress-coping tandem, social support is 
an important coping resource that should be taken into 
account in the development and delivery of interventions. 
  In the course of taking antiretrovirals, nurses are called 
upon to take a preponderant role among persons living with 
HIV. Effectively, the nurse occupies a strategic position 
from which she or he can present information on the 
antiretroviral therapy, while being able to evaluate the stress 
being experienced and support resources available. In this 
way, the nurse can assist the individual to manage stress 
more effectively and to mobilize support. Very delicate or 
fragile individuals (high stress level, isolated) thus are able 
to take advantage of a more intense follow-up from the 
health care team. It is important to evaluate the secondary 
effects connected with the therapy that the individual 
perceives as the most troublesome, and to offer them 
strategies to help them cope. 
CONCLUSION 
  As well as giving a picture of treatment-adherent, 
successfully-treated persons living with HIV, our study 
enabled us to examine the variables associate to their quality 
of life. According to Wu [49] in order to ensure a high level 
of adherence, it is essential to optimize the quality of life of 
persons living with HIV. Mannheimer and colleagues [9] 
have demonstrated that persons with optimal adherence have 
better quality of life after one year, if optimal adherence has 
been maintained over that period. However, the nature of the 
relationship between quality of life and treatment adherence 
is still ambiguous and further studies are necessary [50, 51]. 
As such, we are performing a longitudinal follow-up of this 
cohort of treatment-adherent, successfully-treated persons, so 
that we can examine the dual link of adherence and quality 
of life more closely. 
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